Visit our Booth #5365 at SSG to explore the anti-aging potential of this next-generation NAD+ product.
Research indicates it acts as a more effective NAD+ enhancer than other NAD+ precursors on the market. NAD+ supports cellular energy & DNA repair, but declines with age.
In our UTHPEAK™ Phase II trial, participants took 500 mg daily for 2 months, and memory performance improved by 30%, with 100% of participants showing measurable improvement. Memory improvements remained evident 1 month after dosing stopped, and no adverse events were reported.
Download our new product brochure to see the full clinical results and safety data of UTHPEAK™, and unlock new information on NAD+.
